BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30185652)

  • 21. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
    Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
    BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancer.
    Park S; Lee C; Ku BM; Kim M; Park WY; Kim NKD; Ahn MJ
    BMB Rep; 2021 Jul; 54(7):386-391. PubMed ID: 34154699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
    Vural S; Wang X; Guda C
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):62. PubMed ID: 27587275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
    Ellrott K; Bailey MH; Saksena G; Covington KR; Kandoth C; Stewart C; Hess J; Ma S; Chiotti KE; McLellan M; Sofia HJ; Hutter C; Getz G; Wheeler D; Ding L; ;
    Cell Syst; 2018 Mar; 6(3):271-281.e7. PubMed ID: 29596782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accurate Ensemble Prediction of Somatic Mutations with SMuRF2.
    Huang W; Sim NL; Skanderup AJ
    Methods Mol Biol; 2022; 2493():53-66. PubMed ID: 35751808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
    Krøigård AB; Thomassen M; Lænkholm AV; Kruse TA; Larsen MJ
    PLoS One; 2016; 11(3):e0151664. PubMed ID: 27002637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shimmer: detection of genetic alterations in tumors using next-generation sequence data.
    Hansen NF; Gartner JJ; Mei L; Samuels Y; Mullikin JC
    Bioinformatics; 2013 Jun; 29(12):1498-503. PubMed ID: 23620360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring Tumor Mutational Burden Using Whole-Exome Sequencing.
    Vilimas T
    Methods Mol Biol; 2020; 2055():63-91. PubMed ID: 31502147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
    Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
    J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Human Leukocyte Antigen Typing Algorithm Combined With Currently Available Genotyping Tools Based on Next-Generation Sequencing Data and Guidelines to Select the Most Likely Human Leukocyte Antigen Genotype.
    Lee M; Seo JH; Song S; Song IH; Kim SY; Kim YA; Gong G; Kim JE; Lee HJ
    Front Immunol; 2021; 12():688183. PubMed ID: 34659196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
    Shin H; Sa JK; Bae JS; Koo H; Jin S; Cho HJ; Choi SW; Kyoung JM; Kim JY; Seo YJ; Joung JG; Kim NKD; Son DS; Chung J; Lee T; Kong DS; Choi JW; Seol HJ; Lee JI; Suh YL; Park WY; Nam DH
    Cancer Res Treat; 2020 Jan; 52(1):41-50. PubMed ID: 31096737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
    Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data.
    Fan Y; Xi L; Hughes DS; Zhang J; Zhang J; Futreal PA; Wheeler DA; Wang W
    Genome Biol; 2016 Aug; 17(1):178. PubMed ID: 27557938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.
    van den Akker J; Mishne G; Zimmer AD; Zhou AY
    BMC Genomics; 2018 Apr; 19(1):263. PubMed ID: 29665779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
    Chang CC; Chang YS; Huang HY; Yeh KT; Liu TC; Chang JG
    Hum Pathol; 2018 Aug; 78():151-158. PubMed ID: 29753010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semi-supervised learning for somatic variant calling and peptide identification in personalized cancer immunotherapy.
    Sherafat E; Force J; Măndoiu II
    BMC Bioinformatics; 2020 Dec; 21(Suppl 18):498. PubMed ID: 33375939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole exome sequencing in the rat.
    Foley JF; Phadke DP; Hardy O; Hardy S; Miller V; Madan A; Howard K; Kruse K; Lord C; Ramaiahgari S; Solomon GG; Shah RR; Pandiri AR; Herbert RA; Sills RC; Merrick BA
    BMC Genomics; 2018 Jun; 19(1):487. PubMed ID: 29925311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.